Identification of free-B-ring flavonoids as potent COX-2 inhibitors
AssigneeUnigen Pharmaceuticals, Inc.
InventorsQi Jia, Timothy C. Nichols, Eric E. Rhoden, Scott Waite
Life of this patent
Estimating the term…
Loading patent…
AssigneeUnigen Pharmaceuticals, Inc.
InventorsQi Jia, Timothy C. Nichols, Eric E. Rhoden, Scott Waite
Estimating the term…
The present invention provides a novel method for inhibiting the cyclooxygenase COX-2. The method is comprised of administering a composition containing a Free-enzyme B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids to a host in need thereof. The present also includes novel methods for the prevention and treatment of COX-2 mediated diseases and conditions. The method for preventing and treating COX-2 mediated diseases and conditions is comprised of administering to a host in need thereof an effective amount of a composition containing a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier.
A method for inhibiting the cyclooxygenase enzyme COX-2 comprising administering a composition comprising a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids.
A method for preventing and treating COX-2 mediated diseases and conditions comprising administering to a host in need thereof an effective amount of a composition comprising a Free-B-Ring flavonoid or a composition containing a mixture of Free-B-Ring flavonoids and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.